Favourable outcomes of double-hit/double-expressor lymphoma and high-grade B-cell lymphoma, not otherwise specified after early dose-intensive treatment and up-front autologous stem cell transplantation: a single-centre retrospective experience

Br J Haematol. 2022 Aug;198(4):776-779. doi: 10.1111/bjh.18280. Epub 2022 May 27.

Authors

Tim Strüßmann¹, Franziska Glatzki¹, Monika Engelhardt¹, Roland Mertelsmann¹, Justus Duyster¹, Jürgen Finke¹, Reinhard Marks¹

Affiliation

¹ Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

PMID: 35620830
DOI: 10.1111/bjh.18280

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Hematopoietic Stem Cell Transplantation*
Humans
Lymphoma, Large B-Cell, Diffuse* / pathology
Lymphoma, Large B-Cell, Diffuse* / therapy
Proto-Oncogene Proteins c-myc
Retrospective Studies
Stem Cell Transplantation
Transplantation, Autologous

Substances

Proto-Oncogene Proteins c-myc